Amgen Ruling Could Prevent Slowdowns in Biosimilar Market Entry
July 6, 2020
Valerie Bauman
Bloomberg Law
Axinn partner Chad Landmon was quoted in the Bloomberg Law article, "Amgen Ruling Could Prevent Slowdowns in Biosimilar Market Entry."
Click here to access the article.